Table 1.
Demographic characteristics and laboratory findings on admission.
| Variable | Survivors (n = 298) | Non-survivors (n = 79) | P value |
|---|---|---|---|
| Age, mean (range), years | 41.8 (±22.7) | 46.72 (±25.7) | 0.016 |
| Male, n (%) | 215 (72.1%) | 62 (78.5%) | 0.257 |
| Diabetes mellitus, n (%) | 64 (21.5%) | 24 (30.4%) | 0.096 |
| Hypertension, n (%) | 56 (18.8%) | 20 (25.3%) | 0.199 |
| Cardiovascular disease, n (%) | 6 (2%) | 9 (11.4%) | 0.000 |
| COPD, n (%) | 8 (2.7%) | 8 (10.1%) | 0.013 |
| Dialysis, n (%) | 10 (3.4%) | 8 (10.1%) | 0.012 |
| Haemoglobin g/dl, median (IQR) | 14.8 (13.3–15.8) | 14 (12.2–15.5) | 0.022 |
| Leukocytes ×103/µl, median (IQR) | 7.3 (5.4–10.8) | 9.4 (8.2–13.1) | 0.000 |
| Platelets ×103/µl, median (IQR) | 219 (171.7–301.5) | 243 (180–310) | 0.454 |
| Creatinine mg/dl, median (IQR) | 0.86 (0.7–1) | 0.95 (0.7–1.7) | 0.005 |
| Total bilirubin mg/dl, median (IQR) | 0.77 (0.51–1) | 0.97 (0.6–2.2) | 0.000 |
| Alkaline phosphatase U/l, median (IQR) | 76 (58–102.5) | 102 (68–124) | 0.001 |
| ALT U/l, median (IQR) | 36 (26–56) | 46 (24–100) | 0.040 |
| AST U/l, median (IQR) | 43.5 (31–61.5) | 51 (36–142) | 0.000 |
| CRP mg/dl, median (IQR) | 121 (48–197) | 232 (126.5–321.5) | 0.000 |
| INR, median (IQR) | 1 (1–1.2) | 1 (1–1.2) | 0.888 |
| Albumin g/dl, median (IQR) | 3.5 (3–3.9) | 3.3 (3–3.7) | 0.283 |
| Sodium mmol/l, median (IQR) | 138 (136–140) | 137 (135–140) | 0.421 |
| LDH U/l, median (IQR) | 380.5 (265.7–523.2) | 536 (419–776) | 0.000 |
| MELD score, median (IQR) | 8 (6-10) | 9 (8–16) | 0.000 |
COPD (Chronic Obstructive Pulmonary Disease), ALT (alanine aminotransferase), AST (aspartate aminotransferase), CRP (C reactive protein), INR (international normalized ratio), LDH (lactate dehydrogenase), MELD (Model of End-Stage Liver Disease).